Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q2 2017 · 10-Q
Revenue$0.00$0.00— vs Q2 2016 Net Income-$1.26M-$1.26MN/M vs Q2 2016 EPS Diluted$0.00$0.00— vs Q2 2016 Operating Income-$1,216,043N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$325,096N/M ended Jun 30, 2017 · filed Aug 14, 2017 · 45 d after period end